Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma

Tatsuji Mizukami1, Kouya Shiraishi, Yoko Shimada

  • 1*Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan; †Department of Radiation Oncology, Gunma University Graduate School of Medicine, Gunma, Japan; ‡Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan; §Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan; and ¶Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.

Abstract

Insights

Oncogenic RET fusions in lung adenocarcinoma are driven by illegitimate DNA repair mechanisms, distinct from those in thyroid cancer. These fusions arise from non-specific DNA breaks and various repair pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Oncogenic RET fusion is a driver mutation in lung adenocarcinoma (LADC).
  • The molecular mechanisms behind RET gene rearrangement in lung cancer remain unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms of RET gene rearrangement in lung adenocarcinoma.
  • To identify the DNA repair pathways involved in oncogenic RET fusion formation.

Main Methods:

  • Cloning and analysis of genomic segments containing RET fusion breakpoint junctions.
  • Utilizing genomic polymerase chain reaction and next-generation sequencing.
  • Studied 18 LADC cases, with 16 identified from 671 LADC cases.

Main Results:

  • RET fusion breakpoints predominantly occurred within a specific 2.0-kb region (exon 11 to intron 11).
  • DNA strand breaks at non-specific sites within this region appear to trigger RET fusion.
  • Nonhomologous end joining and break-induced replication were identified as key DNA repair mechanisms contributing to RET fusion.

Conclusions:

  • Oncogenic RET fusion in LADC involves multiple pathways.
  • Illegitimate repair of DNA strand breaks contributes to RET fusion in LADC.
  • The mechanisms differ from those observed in papillary thyroid carcinoma, despite RET fusion also being a driver mutation there.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K